DB Wealth Management Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$143K Sell
303
-24
-7% -$11.1K 0.08% 103
2023
Q3
$142K Hold
327
0.09% 98
2023
Q2
$145K Hold
327
0.09% 92
2023
Q1
$150K Hold
327
0.09% 89
2022
Q4
$168K Sell
327
-38
-10% -$19.3K 0.11% 84
2022
Q3
$166K Hold
365
0.12% 86
2022
Q2
$176K Hold
365
0.12% 85
2022
Q1
$179K Sell
365
-63
-15% -$28.8K 0.11% 92
2021
Q4
$198K Sell
428
-75
-15% -$31.6K 0.12% 86
2021
Q3
$188K Hold
503
0.12% 87
2021
Q2
$192K Hold
503
0.12% 89
2021
Q1
$181K Hold
503
0.12% 91
2020
Q4
$162K Buy
+503
New +$154K 0.12% 94

Other funds holding ELV

DB Wealth Management Group's ELV Position: Q4 2023 in Review

DB Wealth Management Group reduced its Elevance Health (ELV) stake by 7.3% in Q4 2023, selling an estimated $11.1K and leaving 303 shares worth $143K. The position accounts for 0.08% of the portfolio, ranked #103.

DB Wealth Management Group first reported a position in ELV in Q4 2020 and has held it in 13 quarters since. The position peaked at $198K in Q4 2021. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • DB Wealth Management Group held 303 shares of Elevance Health worth $143K as of Q4 2023.
  • DB Wealth Management Group sold 24 Elevance Health shares in Q4 2023, an estimated $11.1K.
  • Elevance Health made up 0.08% of DB Wealth Management Group's portfolio in Q4 2023, its #103 holding.
  • DB Wealth Management Group first reported a position in Elevance Health in Q4 2020 and has held it in 13 quarters since.
  • DB Wealth Management Group's Elevance Health position peaked at $198K in Q4 2021.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on DB Wealth Management Group's 13F filing for Q4 2023, filed 9 Jan 2024.